The trademark application XIIDERI was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on April 12, 2022, and it was registered by office on July 20, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on May 5, 2022. Change of name and address of the trademark registration was recorded on May 17, 2022.